Details for 2020829249
Up to date per 02.04.2026
Actions
Details for 2020829249
Granted/Registered
European Patent
12.10.2022 A
09.04.2025 B1
04.12.2019
US
201962943720 P
15.04.2020
US
202063010524 P
A61K 31/497 20060101AFI20241022BHEP
Owner
Nurix Therapeutics, Inc.1700 Owens Street Suite 205 San Francisco, CA 94158US
Representative
No representatives present
Inventor
SANDS, Arthur T.1700 Owens Street Suite 205 San Francisco, California 94158US
KELLY, Aileen1700 Owens Street Suite 205 San Francisco, California 94158US
Information about Fees